Khiron Life Sciences Corp. (CNW Group/Khiron Life Sciences Corp.)

Khiron Plans to Expand Kuida® Distribution to Spain

Khiron Life Sciences Corp. announced its intent to bring the Company’s Kuida® CBD brand to the Spanish market. This follows receipt of a “no objection” letter from the TSXV specific to Spain, and is subject to meeting all regulatory approvals in that country. With the previously announced fulfillment of E.U. cosmetic notification regulatory requirements Khiron will prepare to commercialize Kuida to a combined skincare market of over US$6.0 billion. (Source: Euromonitor)

“As our European operations ramp up, we are able to bring our unique products, consumer experience and scientific capabilities from Latin America into one of the world’s fastest growing   markets. Entry for our Kuida brand into Spain, and later Switzerland, will represent another milestone in the Company’s strategy to serve consumers across multiple categories and markets,” comments Tejinder Virk, President, Khiron Europe.

Kuida, the first consumer brand of Khiron’s wellness business unit, brings the benefits of cannabidiol (CBD) to a comprehensive portfolio of skin and body care products for women. Kuida was launched in Colombia in October 2018 through retail, wholesale and online channels and is now available nationwide and through e-commerce channels. As the Company expands Kuida distribution in Europe, an initial soft launch in the UK will be followed by a strategic marketing and retail campaign. Kuida will be a featured exhibitor at Cosmoprof Worldwide Bologna 2020, which attracted over 265,000 visitors in 2019 and is the largest such event for attendees to learn more about market leading products and to place orders. For more information on Kuida visit